Immatics (IMTX) Total Liabilities (2019 - 2025)
Immatics (IMTX) reported Total Liabilities of $654.6 million for Q4 2025, down 12.01% on a YoY basis from $743.9 million in Q4 2024, and up 7.98% sequentially from $606.2 million in Q3 2025.
Immatics (IMTX) Total Liabilities (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Total Liabilities data on file, last reported at $654.6 million in Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities fell 12.01% year-over-year to $654.6 million; the trailing twelve-month figure through Dec 2025 stood at $654.6 million (down 12.01% YoY), and the FY2025 full-year result was $635.3 million, down 15.68% from the prior year.
- Total Liabilities rose to $654.6 million in Q4 2025, from $606.2 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $743.9 million in Q4 2024 to a low of $193.7 million in Q2 2021.
- A 5-year average of $396.0 million and a median of $337.0 million in 2022 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities plunged 54.32% in 2024 and surged 178.7% in 2025, its largest moves.
- Tracing IMTX's Total Liabilities over 5 years: stood at $199.8 million in 2021, then climbed by 4.41% to $208.6 million in 2022, then jumped by 50.78% to $314.5 million in 2023, then surged by 136.5% to $743.9 million in 2024, then declined by 12.01% to $654.6 million in 2025.
- Business Quant data shows IMTX's Total Liabilities at $654.6 million in Q4 2025, $606.2 million in Q3 2025, and $642.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 753.82 Mn |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | 654.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 654.58 Mn |
| Sep 30, 2025 | 606.22 Mn |
| Jun 30, 2025 | 642.16 Mn |
| Mar 31, 2025 | 674.99 Mn |
| Dec 31, 2024 | 743.90 Mn |
| Sep 30, 2024 | 217.52 Mn |
| Jun 30, 2024 | 264.59 Mn |
| Mar 31, 2024 | 281.36 Mn |
| Dec 31, 2023 | 314.55 Mn |
| Sep 30, 2023 | 476.20 Mn |
| Jun 30, 2023 | 446.66 Mn |
| Mar 31, 2023 | 406.25 Mn |
| Dec 31, 2022 | 208.61 Mn |
| Sep 30, 2022 | 357.22 Mn |
| Jun 30, 2022 | 393.00 Mn |
| Mar 31, 2022 | 316.70 Mn |
| Dec 31, 2021 | 199.79 Mn |
| Sep 30, 2021 | 234.57 Mn |
| Jun 30, 2021 | 193.73 Mn |
| Mar 31, 2021 | 286.81 Mn |